Literature DB >> 25316066

The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth.

S S Witkin1.   

Abstract

Ascending bacterial infection is implicated in about 40-50% of preterm births. The human vaginal microbiota in most women is dominated by lactobacilli. In women whose vaginal microbiota is not lactobacilli-dominated anti-bacterial defence mechanisms are reduced. The enhanced proliferation of pathogenic bacteria plus degradation of the cervical barrier increase bacterial passage into the endometrium and amniotic cavity and trigger preterm myometrial contractions. Evaluation of protocols to detect the absence of lactobaciili dominance in pregnant women by self-measuring vaginal pH, coupled with measures to promote growth of lactobacilli are novel prevention strategies that may reduce the occurrence of preterm birth in low-resource areas.
© 2014 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Bacterial vaginosis; d-lactic acid; l-lactic acid; lactobacilli; preterm birth; vaginal microbiome

Mesh:

Substances:

Year:  2014        PMID: 25316066     DOI: 10.1111/1471-0528.13115

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  41 in total

1.  Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function.

Authors:  Ellen M Wilkinson; Paweł Łaniewski; Melissa M Herbst-Kralovetz; Rebecca M Brotman
Journal:  J Infect Dis       Date:  2019-11-06       Impact factor: 5.226

Review 2.  Impact of maternal nutrition in pregnancy and lactation on offspring gut microbial composition and function.

Authors:  Derrick M Chu; Kristen M Meyer; Amanda L Prince; Kjersti M Aagaard
Journal:  Gut Microbes       Date:  2016-09-29

Review 3.  Role of priority effects in the early-life assembly of the gut microbiota.

Authors:  Daniel Sprockett; Tadashi Fukami; David A Relman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-24       Impact factor: 46.802

Review 4.  Putative functions of tissue kallikrein-related peptidases in vaginal fluid.

Authors:  Carla M J Muytjens; Stella K Vasiliou; Katerina Oikonomopoulou; Ioannis Prassas; Eleftherios P Diamandis
Journal:  Nat Rev Urol       Date:  2016-09-07       Impact factor: 14.432

5.  The Maternal Infant Microbiome: Considerations for Labor and Birth.

Authors:  Alexis B Dunn; Sheila Jordan; Brenda J Baker; Nicole S Carlson
Journal:  MCN Am J Matern Child Nurs       Date:  2017 Nov/Dec       Impact factor: 1.412

6.  Cooperative Interactions between Trichomonas vaginalis and Associated Bacteria Enhance Paracellular Permeability of the Cervicovaginal Epithelium by Dysregulating Tight Junctions.

Authors:  Annabel S Hinderfeld; Niha Phukan; Ann-Katrein Bär; Anthony M Roberton; Augusto Simoes-Barbosa
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

7.  ENGAGING NATIVE AMERICANS IN GENOMICS RESEARCH.

Authors:  Ripan S Malhi; Alyssa Bader
Journal:  Am Anthropol       Date:  2015-12-04

Review 8.  Lactic acid alleviates stress: good for female genital tract homeostasis, bad for protection against malignancy.

Authors:  Steven S Witkin
Journal:  Cell Stress Chaperones       Date:  2017-10-23       Impact factor: 3.667

9.  The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.

Authors:  Laura L Reimers; Supriya D Mehta; L Stewart Massad; Robert D Burk; Xianhong Xie; Jacques Ravel; Mardge H Cohen; Joel M Palefsky; Kathleen M Weber; Xiaonan Xue; Kathryn Anastos; Howard Minkoff; Jessica Atrio; Gypsyamber D'Souza; Qian Ye; Christine Colie; Christine P Zolnik; Gregory T Spear; Howard D Strickler
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

Review 10.  The vaginal microbiota, host defence and reproductive physiology.

Authors:  Steven B Smith; Jacques Ravel
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.